NEW YORK--(BUSINESS WIRE)--Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better and healthier lives, today announced a groundbreaking partnership through its commercial business, Noom for Work, with Liviniti, a national pass-through and transparent PBM, to offer a comprehensive metabolic offering for plan sponsors and their employees consisting of Noom Weight, Noom Diabetes Prevention Program, and Noom’s newest offering: Noom GLP-1 Companion..

纽约--（商业新闻短讯）--致力于慢性病预防和赋予人们更好、更健康生活的领先数字医疗保健公司Noom今天宣布，通过其商业业务Noom for Work与Liviniti建立了开创性的合作伙伴关系，Liviniti是一家全国通行且透明的PBM，为计划赞助商及其员工提供全面的代谢服务，包括Noom体重、Noom糖尿病预防计划和Noom的最新产品：Noom GLP-1 Companion。。

The Noom GLP-1 Companion is a comprehensive program designed by Noom’s Chief of Medicine, Linda Anegawa MD, FACP, Dipl. ABOM, to help members through every phase of their weight loss journey, from the initial onboarding stage, through weight loss, and onto the crucial phases of off-ramping medication and weight maintenance.

Noom GLP-1 Companion是由Noom的医学主管Linda Anegawa MD，FACP，Dipl设计的综合程序。ABOM，帮助会员完成减肥旅程的每个阶段，从最初的入职阶段，到减肥，再到药物治疗和体重维持的关键阶段。

It offers comprehensive assistance in nutrition, exercise, and ensures adherence to medications to pave the way for sustained success..

它在营养、运动方面提供全面帮助，并确保坚持服用药物，为持续成功铺平道路。。

“GLP-1s are an important new tool for weight loss,” said Dr. Anegawa. “But, they alone are not enough. As many as 68% of people don’t remain on a GLP-1 long-term1 for a variety of reasons. And for those that do, the rapid weight loss can endanger lean muscle mass unless care is taken to increase protein intake and engage in resistance training.

Anegawa博士说：“GLP-1是减肥的重要新工具。”。“但是，仅仅靠它们是不够的。多达68%的人由于各种原因没有长期服用GLP-1。对于那些长期服用GLP-1的人来说，快速减肥可能会危及瘦肌肉质量，除非注意增加蛋白质摄入量并进行阻力训练。

We also know that when people stop taking the medication without adequate lifestyle support, the weight comes back. With this weight regain and without rebuilding muscle, further insulin resistance can leave the patient worse off. Noom’s GLP-1 Companion program was designed to weave together comprehensive coaching and content support with psychology-based habit change into a holistic treatment plan for members who utilize GLP-1 medication.”.

我们还知道，当人们在没有足够的生活方式支持的情况下停止服用药物时，体重就会恢复。随着体重的恢复而不重建肌肉，进一步的胰岛素抵抗可能会使患者病情恶化。努姆的GLP-1同伴计划旨在将综合指导和内容支持与基于心理学的习惯改变结合起来，为使用GLP-1药物的成员制定一个整体治疗计划。”。

The Noom GLP-1 Companion includes the following features:

Noom GLP-1配套产品包括以下功能：

Integration with pharmacy benefit manager prior authorization processes to maximize GLP-1 impact and outcomes

与药房福利经理事先授权流程整合，以最大程度地发挥GLP-1的影响和结果

A tailored approach to Noom’s well-known “green-yellow-orange” food color scheme with over 200,000 protein-rich foods now marked “green” for Noom members taking a GLP-1

一种针对Noom著名的“绿-黄-橙”食物颜色方案的量身定制方法，现在有超过200000种富含蛋白质的食物被标记为“绿色”，供Noom成员服用GLP-1

A protein-tracking tool, helping members to hit their daily protein requirements, in addition to important food logging, water tracking, and step-tracking tools

一种蛋白质跟踪工具，除了重要的食物记录、水分跟踪和步进跟踪工具外，还可以帮助成员满足日常蛋白质需求

Fitness-focused lessons and videos for people at all activity levels, designed to prevent the muscle loss associated with GLP-1 use

为所有活动水平的人提供以健身为重点的课程和视频，旨在防止与GLP-1使用相关的肌肉损失

Expert-led guidance and content on common side effects, complications, and resilience surrounding weight loss medications

专家主导的关于减肥药物常见副作用、并发症和恢复力的指导和内容

Customized, interactive mini-courses focused on “aha moments” to drive long-term behavior change around nutrition, fitness, and goal-setting to support successful tapering and off-ramping from GLP-1s

定制的交互式迷你课程侧重于“aha时刻”，以推动围绕营养、健身和目标设定的长期行为改变，以支持GLP-1的成功减量和减量

As a pioneer in pharmacy benefit innovation, Liviniti is taking a leading role with Noom as the first PBM to help employers optimize outcomes in weight management with Noom GLP-1 Companion. “We are proud to partner with Noom to offer Liviniti clients a comprehensive weight management solution,” said LeAnn Boyd, Liviniti CEO.

作为药房福利创新的先驱，Liviniti与Noom一起作为第一个PBM发挥领导作用，帮助雇主优化Noom GLP-1 Companion的体重管理结果。Liviniti首席执行官莱恩·博伊德（LeannBoyd）表示：“我们很荣幸与Noom合作，为Liviniti客户提供全面的体重管理解决方案。”。

“By innovating to mitigate the obesity trend, we can assist members on their weight-loss journeys — leading to better health and the potential for plan savings.”.

“通过创新来缓解肥胖趋势，我们可以帮助会员减肥，从而改善健康状况并节省计划。”。

“The Noom GLP-1 Companion represents a commitment by Noom to provide our clients the most comprehensive GLP-1 course of care,” said Noom CEO Geoff Cook. “We extended our flagship program to ensure an easy on-ramping for Liviniti members seeking access to a GLP-1 for weight loss. Lifestyle is critical to GLP-1 success, and we’re incredibly excited to deliver our tailored curriculum and coaching model to support Liviniti members taking weight loss medication.”.

Noom首席执行官杰夫·库克（GeoffCook）表示：“Noom GLP-1伴侣代表了Noom为客户提供最全面的GLP-1护理服务的承诺。”。“我们扩展了旗舰计划，以确保寻求获得GLP-1减肥药的Liviniti会员轻松上马。生活方式对GLP-1的成功至关重要，我们非常高兴能够提供量身定制的课程和辅导模式，以支持Liviniti会员服用减肥药。”。

Noom has been at the forefront of GLP-1 companion support since 2018, when it developed and launched a GLP-1 companion program for an early GLP-1 approved for chronic weight management. That program grew to over 65,000 people engaging with the app. The commercial release of Noom GLP-1 Companion builds on this early success and is available within Noom Weight and the Noom Diabetes Prevention Program..

自2018年以来，Noom一直处于GLP-1伴侣支持的最前沿，当时它开发并启动了一个GLP-1伴侣计划，用于早期GLP-1被批准用于慢性体重管理。该程序吸引了65000多人使用该应用程序。Noom GLP-1 Companion的商业版建立在这一早期成功的基础上，可在Noom Weight和Noom糖尿病预防计划中获得。。

For Liviniti clients that wish to assist their members in addressing stress and mental wellness, Noom’s stress management program Noom Mood will also be available. The programs will be available to those participating Liviniti clients and their respective members beginning in March 2024.

对于希望帮助其成员解决压力和心理健康问题的Liviniti客户，还将提供Noom的压力管理计划Noom Mood。这些计划将于2024年3月开始向参与Liviniti的客户及其各自的成员提供。

About Noom

关于Noom

Noom is the digital healthcare company empowering people to live better, longer lives. Noom connects people to content, coaching, community, and clinicians to improve whole-person health. Noom also works with leading health plans and employers offering Noom Med COE, Noom GLP-1 Companion, Noom Healthy Weight, and Noom Diabetes Prevention to millions of covered lives.

Noom是一家数字医疗保健公司，它使人们能够过上更好、更长的生活。Noom将人们与内容、辅导、社区和临床医生联系起来，以改善整个人的健康。Noom还与领先的健康计划和雇主合作，为数百万受保人提供Noom Med COE、Noom GLP-1 Companion、Noom health Weight和Noom糖尿病预防服务。

The company has been awarded multiple grants from the National Institutes of Health and was the first mobile application to be recognized by the Centers for Disease Control and Prevention as a certified diabetes prevention program. Headquartered in New York City, Noom has been named one of Inc.’s Best Places to Work, Quartz’s Best Workplaces for Remote Workers, and Fortune’s Best Workplaces in Technology.

该公司获得了美国国立卫生研究院（National Institutes of Health）的多项资助，是美国疾病控制与预防中心（Centers for Disease Control and Prevention）认可的首个经认证的糖尿病预防计划移动应用程序。总部位于纽约市的努姆被评为Inc.最佳工作场所之一、Quartz最佳远程工作者工作场所和Fortune最佳技术工作场所。

To learn more about Noom, visit noom.com..

要了解更多关于Noom的信息，请访问Noom.com。。

1 Prime Therapeutics, “Real-World Analysis of GLP-1A Drugs for Weight Loss Finds Low Adherence and Increased Cost in First Year,” Prime Therapeutics, accessed [January 8, 2024], https://www.primetherapeutics.com/news/real-world-analysis-of-glp-1a-drugs-for-weight-loss-finds-low-adherence-and-increased-cost-in-first-year/..

1 Prime Therapeutics，“用于减肥的GLP-1A药物的现实世界分析发现，第一年的依从性低，成本增加”，Prime Therapeutics，访问[2024年1月8日]，https://www.primetherapeutics.com/news/real-world-analysis-of-glp-1a-drugs-for-weight-loss-finds-low-adherence-and-increased-cost-in-first-year/..